(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.95%) $81.15
(-2.16%) $1.948
(-0.47%) $2 292.10
(-0.22%) $26.60
(-0.43%) $944.10
(0.13%) $0.938
(0.28%) $11.13
(0.17%) $0.802
(0.00%) $93.45
5 days till quarter result
(amc 2024-05-06)
Expected move: +/- 6.34%
@ $7.90
发出时间: 14 Feb 2024 @ 05:00
回报率: -23.92%
上一信号: Feb 13 - 22:30
上一信号:
回报率: 0.00 %
Live Chart Being Loaded With Signals
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications...
Stats | |
---|---|
今日成交量 | 386 513 |
平均成交量 | 701 961 |
市值 | 786.25M |
EPS | $0 ( 2024-02-28 ) |
下一个收益日期 | ( $0 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -66.78 |
ATR14 | $0.00500 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Yan Ming | Sell | 20 000 | Common Stock |
2024-04-09 | Yan Ming | Sell | 1 500 | Common Stock |
2024-04-09 | Yan Ming | Sell | 400 | Common Stock |
2024-03-20 | Busque Philippe | Buy | 5 464 | Common Stock |
2024-03-20 | Busque Philippe | Sell | 2 129 | Common Stock |
INSIDER POWER |
---|
9.24 |
Last 99 transactions |
Buy: 2 029 549 | Sell: 1 974 867 |
音量 相关性
Cytek Biosciences, Inc. 相关性 - 货币/商品
Cytek Biosciences, Inc. 财务报表
Annual | 2023 |
营收: | $193.02M |
毛利润: | $109.43M (56.69 %) |
EPS: | $-0.0898 |
FY | 2023 |
营收: | $193.02M |
毛利润: | $109.43M (56.69 %) |
EPS: | $-0.0898 |
FY | 2022 |
营收: | $164.04M |
毛利润: | $100.97M (61.56 %) |
EPS: | $0.0192 |
FY | 2021 |
营收: | $127.95M |
毛利润: | $79.14M (61.86 %) |
EPS: | $0.0433 |
Financial Reports:
No articles found.
Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。